Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 531 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Completed

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma

NCT01798134

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Klinikum der Universitat Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • SLK-Kliniken Heilbronn GmbH Heilbronn, Baden-Wurttemberg, Germany
  • Klinikum Stuttgart- Katharinenhospital Stuttgart, Baden-Wurttemberg, Germany
  • Klinikum Bogenhausen München, Bavaria, Germany
View Trial Details
Completed

Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.

NCT01035229

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • Compassionate Cancer Care Medical Group CCCMG Fountain Valley, California, United States
  • University of California San Diego - Moores Cancer Center SC - 3 La Jolla, California, United States
  • California Pacific Medical Center California Pacific Med San Francisco, California, United States
View all 131 locations
View Trial Details
Completed

Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma

NCT01777594

Conditions
Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +9 more
Locations
  • Mary Crowley Cancer Research Center Dallas, Texas, United States
  • Oncology Consultants, PA Houston, Texas, United States
  • University of Texas Health Sciences Center at Houston, Memorial Hermann Cancer Center Houston, Texas, United States
  • The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
View Trial Details
Completed

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

NCT01559844

Conditions
Adenocarcinoma, Blood-Borne Infections, Bronchial Diseases, +29 more
Locations
  • UCLA Medical Center-The Pfleger Liver Institute Los Angeles, California, United States
  • UC San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 15 locations
View Trial Details

Related conditions